← Leaderboards
Paul B Robbins
Stanford University
$1,201,274
Attributed
$1,201,274
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232K · FY2005–09$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,201,274 · 2
By mechanism
P01$1,121,762 · 1
F32$79,512 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Paul A Khavari$40,653,927
- Edgar G. Engleman$35,389,843
- Anthony E Oro$25,372,453
- Matt Peter Marinkovich$8,061,995
- Olivia M Martinez$20,491,021
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyAnakinraApoptosisAnimalsAntibodiesAntigen PresentationAngiogenesisBaseCd4 Positive T LymphocytesCd8b1 GeneCell CountCell PhysiologyCellsCell TypeAdenovirus VectorCohortCollaborationsCross-PrimingCxcl10 GeneCytokineCytokine GeneCytolysisCytotoxicityAdenoviruses
Grant awards (7)
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY$212,186
P01 · FY2009 · CA · contact PI
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY$228,892
P01 · FY2008 · CA · contact PI
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY$223,608
P01 · FY2007 · CA · contact PI
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY$232,049
P01 · FY2006 · CA · contact PI
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY$225,027
P01 · FY2005 · CA
SUSTAINED GENETIC CORRECTION OF EPIDERMOLYSIS BULLOSA$41,996
F32 · FY2001 · AR
SUSTAINED GENETIC CORRECTION OF EPIDERMOLYSIS BULLOSA$37,516
F32 · FY2000 · AR